MAPT and Mental deterioration: Future real-world clinical data, with available postmortem evaluation, could also help us investigate the pathological correlates of the underexplored and relatively rare isolated tau positivity (Aβ(-)T(+), 1.19% of our ADNI sample) and better understand the role of comorbidities in individuals with clinically relevant cognitive decline and discordant Aβ and tau status.